1. Home
  2. KRYS vs GBTG Comparison

KRYS vs GBTG Comparison

Compare KRYS & GBTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • GBTG
  • Stock Information
  • Founded
  • KRYS 2015
  • GBTG 2014
  • Country
  • KRYS United States
  • GBTG United States
  • Employees
  • KRYS N/A
  • GBTG N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • GBTG Computer Software: Prepackaged Software
  • Sector
  • KRYS Health Care
  • GBTG Technology
  • Exchange
  • KRYS Nasdaq
  • GBTG Nasdaq
  • Market Cap
  • KRYS 4.3B
  • GBTG 3.6B
  • IPO Year
  • KRYS 2017
  • GBTG N/A
  • Fundamental
  • Price
  • KRYS $150.49
  • GBTG $8.26
  • Analyst Decision
  • KRYS Strong Buy
  • GBTG Strong Buy
  • Analyst Count
  • KRYS 10
  • GBTG 3
  • Target Price
  • KRYS $204.90
  • GBTG $9.83
  • AVG Volume (30 Days)
  • KRYS 422.6K
  • GBTG 1.1M
  • Earning Date
  • KRYS 08-04-2025
  • GBTG 08-05-2025
  • Dividend Yield
  • KRYS N/A
  • GBTG N/A
  • EPS Growth
  • KRYS 36.22
  • GBTG N/A
  • EPS
  • KRYS 4.91
  • GBTG N/A
  • Revenue
  • KRYS $359,205,000.00
  • GBTG $2,440,000,000.00
  • Revenue This Year
  • KRYS $34.33
  • GBTG $2.77
  • Revenue Next Year
  • KRYS $47.84
  • GBTG $4.42
  • P/E Ratio
  • KRYS $30.77
  • GBTG N/A
  • Revenue Growth
  • KRYS 116.08
  • GBTG 3.61
  • 52 Week Low
  • KRYS $122.80
  • GBTG $5.78
  • 52 Week High
  • KRYS $207.84
  • GBTG $9.60
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 56.41
  • GBTG 77.71
  • Support Level
  • KRYS $142.51
  • GBTG $7.78
  • Resistance Level
  • KRYS $147.58
  • GBTG $7.96
  • Average True Range (ATR)
  • KRYS 4.78
  • GBTG 0.30
  • MACD
  • KRYS 0.39
  • GBTG 0.07
  • Stochastic Oscillator
  • KRYS 92.81
  • GBTG 98.49

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About GBTG Global Business Travel Group Inc.

Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.

Share on Social Networks: